# Buprenorphine and Naloxone

NDC: 0228-3155
Generic name: Buprenorphine and Naloxone
Labeler / Manufacturer: Actavis Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: SUBLINGUAL
Marketing started: 20130304

FDA application: ANDA091422

## Active ingredients

- BUPRENORPHINE HYDROCHLORIDE: 8 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0228-3155"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0228-3155
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6cccf229-9611-4b6f-8f1b-acc8ff1ed3f8